Pfizer's CEO is 'cautiously optimistic' about RFK Jr. as Trump's health secretaryByBruce GilUpdatedFebruary 4, 2025
Trump's tariffs could exacerbate drug shortages and raise prices, industry warnsByBruce GilPublishedFebruary 3, 2025
The FDA approved a new non-opioid painkiller. Its maker's stock is risingByWilliam GavinUpdatedJanuary 31, 2025
Trump's Medicaid freeze, Ozempic for kidney disease, and 23andMe for sale: Pharma news roundupByBruce GilPublishedJanuary 31, 2025
The Trump administration promises 'greater transparency' in drug price negotiationsByBruce GilPublishedJanuary 29, 2025
RFK Jr. is open to lowering drug prices — using a policy championed by Elizabeth WarrenByBruce GilUpdatedJanuary 28, 2025
Big Pharma has already raised the prices of hundreds of drugs this yearByBruce GilUpdatedJanuary 28, 2025
LinkedIn co-founder Reid Hoffman just raised $25 million to take on cancer with AIByBruce GilUpdatedJanuary 28, 2025
Ozempic maker Novo Nordisk will cap insulin prices to settle a lawsuitByQuartz Intelligence NewsroomPublishedJanuary 27, 2025
Purdue Pharma and the Sacklers have settled opioid lawsuits for $7.4 billionByQuartz Intelligence NewsroomPublishedJanuary 24, 2025
An Ozempic alternative shows promising weight loss results — and Novo Nordisk stock surges 12%ByRocio FabbroUpdatedJanuary 24, 2025
